Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Double-Blind, Placebo-Controlled Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)

To see complete record on, please visit this link

Id: NCT03149991

Organisation Name: Massachusetts General Hospital

Overal Status: Completed

Start Date: September 14, 2017

Last Update: July 24, 2020

Lead Sponsor: Massachusetts General Hospital

Brief Summary: This is a multi-site, double-blind, placebo-controlled study of the acute efficacy of brexpiprazole or placebo in combination with intranasal ketamine added to ongoing, stable, and adequate antidepressant therapy (ADT) in the treatment of adults with Major Depressive Disorder with Treatment Resistant Depression.

  • Depression

Total execution time in seconds: 0.40105509757996